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Key Messages: 
 This is the first piece of research evaluating healthcare professionals (HCPs) and young 
persons awareness of the NCSP 
 HCPs have variable awareness of the NCSP guidance 
 GUM-clinic attending young adults were found to report testing relatively frequently 











The extent to which healthcare professionals (HCPs) and young people (YP) are aware of, 
and adhere to, National Chlamydia Screening Programme (NCSP) recommendations on 
testing frequency is unclear. To address this two cross- sectional surveys in 2015–2016: one 
among genitourinary medicine (GUM) and non-GUMCPs (n 109) and the other among YP 
attending a GUM clinic in England (n 195). For both, questions were designed to measure 
awareness of NCSP guidance and whether respondents acted on that knowledge. This 
included questions about YP’s most recent test(s) (if ever) and the time since first and last 
sex with their most recent partners. Knowledge of NCSP testing guidelines varied among 
both GUM and non-GUM HCP respondents. However, lack of knowledge of the guidelines 
did not preclude HCPs from recommending testing in line with NCSP recommendations in 
practice. While most YP were not aware of NCSP recommendations, around two-thirds had 
tested for Chlamydia at least once in the last year. However, testing seldom appeared to 
coincide with partnership change. There is a knowledge gap and a discord between testing 
recommendations and practice. Interventions are needed to encourage appropriate testing 






Chlamydia trachomatis is the most commonly diagnosed bacterial sexually transmitted infection 
(STI) in the UK with over 200,000 people diagnosed in 2016.1 The greatest prevalence of 
infection is found among sexually-experienced 16–24 year olds (3.1% in women; 2.3% in men) 
with the majority of those infected experiencing no symptoms.3 Left untreated, Chlamydia can 
cause significant and costly adverse reproductive health problems including ectopc pregnancy 
and infertility.3 Transmission  may  also  occur  to sexual partners and to the neonate.3  
 
In   England,   the   National   Chlamydia  Screening Programme (NCSP) was introduced in 
2003 with the aims of preventing and controlling Chlamydia through the  detection  and  prompt  
treatment  of  infection  in people aged 15–24 years. Reinfection among young people (YP) who 
have been treated for Chlamydia is estimated to be 10–30%.4 As a result, the  NCSP advises 
that all sexually-active men and women under the age of 25 are tested annually, on change of 
sexual partner and three months following treatment.5 Adherence to NCSP guidelines is 
monitored through local, regional  and  national  audit  and  surveil- lance systems. 
 
NCSP aims to deliver high volume, high-quality screening to YP by embedding Chlamydia 
screening within primary care and sexual health services. The NCSP encourages commissioners 
and  providers  to  use core services including: sexual and reproductive health services; internet 
testing; general practice; abortion services and community pharmacies. 
 
Appropriate testing in accordance with the NCSP recommendations may require knowledge of 
these recommendations among healthcare professionals (HCPs) and YP as well as the feeling 
that a test is needed in relation to sexual activity. There is little understanding of the testing 
patterns of YP in relation to the timing of sex with partners. For example, during a sexual health 
consultation, sexually-active YP will be asked when they last had sex, and the number of 
partners in the last three months will be documented. However, the timing of sexual health 
screens in relation to changes in partners is often undocumented. Individuals may have two or 
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more sexual partnerships at a time (concurrency) which further adds to the challenges of 
understanding patterns of testing in relation to sexual partner change.2 Timing of testing is crucial 
for the prevention of transmission and prevention of sequelae, as treatment after transmission 
events, or after upper reproductive tract damage has occurred, will have  much less benefit for 
the same cost. In this study, we aimed to establish (1) HCPs’ and YP’s knowledge of NCSP 
testing recommendations; (2) testing practices among HCPs in relation to knowledge of  
guidance  and (3) testing practices among YP in relation  to timing since first sex with most 




We conducted two cross-sectional surveys in 2015-2016: one among HCPs and the other among 
YP attending a genitourinary medicine (GUM) clinic. In both surveys, questions were designed to 
measure awareness of the NCSP testing guidance and whether respondents acted on that 
knowledge. Both questionnaires were piloted with a small group of HCPs and YP in order to 
optimise question wording and improve survey validity. 
 
HCP survey: This was an online survey of HCPs working in GUM and Sexual and Reproductive 
Health across England (see online Appendix 1). HCPs were invited between December 2015 and 
April 2016 through the British Association of Sexual Health and  HIV  (BASHH)  and Faculty of 
Sexual and Reproductive Health  (FSRH) newsletters and  snowball  sampling.  We  asked 
respondents whether they could correctly identify age limits for Chlamydia screening (15–24 years) 
and used hypothetical scenarios to determine HCPs’ aware- ness of and adherence to NCSP 
recommendations for testing annually, on change of partner and re-testing following treatment for 
an infection.  Respondents were categorised as being aware of each recommendation if they 
responded correctly to each scenario. Respondents were then informed of the NCSP 
recommendation and asked whether, in practice, they always/sometimes/rarely/never 




regardless of whether they were aware   of NCSP guidance. 
 
YP survey: This was a  clinic-based  convenience  survey  of  young adults attending a GUM clinic 
in  Bolton,  a  large town in  Greater  Manchester,  UK,  with  areas  of high-level deprivation. We 
used a self-completion pen-and-paper questionnaire (online Appendix 2), which the reception staff  
distributed  to  all  those  aged 15–24 years who attended the clinic between 26 May and 8 July 
2016. We anticipated this  would  result in a sample of 200 patients, which we believed would 
provide a sufficient level of precision for the purposes of this exploratory study. A sample size 
of 200 patients would be sufficient to estimate a 20% proportion who report having/expecting to 
have a Chlamydia test upon change of sexual partner  to  within 6  percentage  points;  a  50%  
proportion  can  be estimated within 7 percentage points.  
 
The survey included questions about YP’s awareness of NCSP recommendations, and their history 
of Chlamydia testing and diagnosis. The time between commencing   a new sexual partnership 
and having a Chlamydia test represents a period when  a  young  person  is  at  risk of  any  newly-
acquired  infection  going  untreated.  We therefore explored the timing of testing in relation to 
sexual partnership formation by asking respondents to report the time (days/weeks/months) since 
the first and last sex with their most  recent sexual partner(s)   (at most three) and most recent 
Chlamydia test(s) (again, at most three). These data were then used to estimate the time between 
the most recent  test  and  first sex with their most recent partner. Given the approximate nature of 
these data, and  because  they  are potentially subject to recall bias, the following broad   categories   
were   used:   the   test   occurred (1) ‘well over a year after first sex’; (2) ‘around one year after 
first sex’; (3) ‘around six months after first sex’; (4) ‘a couple of months after first sex’; (5) ‘at the 
time of first sex’; (6) ‘a couple of months before first sex’; (7) ‘around six months before first sex’; 
(8) ‘around one year before first sex’; (9) ‘well over a year before first sex’. 
 
Ethics approval was not required for the HCP  survey as this was  conducted as a service evaluation  
of NCSP delivery. Ethics approval for the YP survey was obtained from North West – Greater 
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Manchester Central NHS Research Ethics Committee, reference number 16/NW/0217. 
 
Descriptive analyses were performed using Excel and Stata, specifically, percentages were 
calculated and where applicable compared using the chi-square test. Statistical significance was 
considered as p < 0.05. The average age at first sex was calculated as the median with the inter-
quartile range used as a measure of spread, among participating YP who reported that they had 





HCP survey:  
One hundred and nine HCPs completed the online questionnaire. Of these, 69 were GUM HCPs 
(64 doctors; 4 nurses; 1 health advisor) and 40 were non-GUM HCPs (26 doctors, including 7 
GPs; 14 nurses). 
 
Awareness of the key NCSP recommendation that 15–24 year olds should be tested annually 
was low among HCPs: only 19% of respondents accurately identified the recommended age 
group for the NCSP and only 26% reported being aware of the recommendation to test annually 
(Table 1). A higher proportion of HCPs were aware of the need to test on change of partner 
(70%) and three months after a diagnosis (58%). There was no statistically significant difference 
in awareness of guidance for age limit, annual testing or re-test between specialties (GUM vs. 
non-GUM). However, there was a statistically significant difference (p 0.007) between specialties 
with regard to awareness of re-test requirements. 
 
Despite relatively low awareness of some of the specific recommendations, the proportion of 
respondents who reported that they sometimes or always recommended testing annually, on 
change of sexual partner and three months after a positive test was relatively high in both those 
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who were aware of recommendations and those who were not (Table 1). 
 
YP survey: 
Six hundred and eighty patients aged 15 to 24 years attended the clinic during  the  study  period;  
195 (29%) completed the paper  questionnaire.  As  shown in Table 2, YP had relatively low levels 
of awareness  of the NCSP recommendations to test annually (12%) and on change of partner 
(37%). However, annual testing was still reported by 66% of respondents in the YP’s survey and 
56% reported having been tested for Chlamydia in the last year. Three-quarters of respondents 
indicated they would be happy to be offered a Chlamydia test each time they saw a doctor or 
nurse. 
 
In total, 117 respondents had valid responses on  both the timing of their  most  recent  Chlamydia  
test as well and the timing of first sex with their most  recent partner enabling the relative timing  of 
Chlamydia test to be established for these YP. On aver- age (median), respondents’ most recent 
test was around six weeks after first sex with their partner; however, there was substantial variation. 
As shown in Figure 1, while 24% reported having had a Chlamydia test  within a few months of first 
sex occurring with the partner, 31% had not been tested since  having  sex  with the partner and 





Knowledge of NCSP testing guidelines varied among both GUM and non-GUM HCP respondents 
in our cross-sectional survey. However, in practice, lack of knowledge of the guidelines did not 
preclude HCPs from recommending testing in line with NCSP recommendations. The majority of 
respondents to the YP survey were not aware of NCSP recommendations. However, around two-
thirds had been tested for Chlamydia at least once in the last year, suggesting that knowledge of 
the NCSP guidance is not a pre- requisite for health-seeking behaviour in this clinic- attending 
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population. Our comparison of reported testing history in relation to sexual partnership formation 
suggested that Chlamydia testing seldom coincided with partnership formation. 
 
These surveys collected information from two populations that are key to the success of the 
NCSP.   The YP survey was the first study that we are aware of that has attempted to look in 
detail at the timing of Chlamydia testing in relation to sexual partnerships in the context of the 
NCSP. 
 
There were, however, some limitations. With regard to the HCP survey, we are unable to quantify 
the response rate, since we do not know how many emails were sent out via the BASHH and FSRH 
news- letters. We do know that no reminder emails were sent in this time. The resources available 
for our exploratory study meant that we were limited to using a convenience sample and so knew 
that we would not achieve views that were representative of HCPs across England. The relatively 
small sample size limited our ability to explore differences between professional groups. However, 
incomplete awareness of, and adherence to, recommendations were seen among both GUM and 
non-GUM professionals, suggesting there is room for the NCSP to improve awareness among HCP 
from both groups. Our findings may also be biased towards an overestimate of awareness and 
adherence to recommendations; we aimed to reach a sample that was representative of HCPs 
working in sexual health by accessing them through professional bodies but response bias may 
have occurred as people who are aware of the guidance may have been more inclined to complete 
the survey. Additionally, we used scenarios to test respondent awareness, which did not leave room 
for nuanced views. Although we piloted the questionnaire to try to optimise question validity, it is 
possible that respondents have some awareness of the recommendations but that they responded 
in a way we would not have expected. For example, we provided a graph for HCPs to mark on 
where they felt the age range for testing within the NCSP fell. It may well have been more 
appropriate to ask for a written response for the lower age limit and for the higher age limit. We 
have recognised in our data when a respondent identified the age limits within a year of each end 




The YP’s survey has limited generalizability, because the sampling frame was clinic attendees who 
attended one particular clinic in England and the number of YP who filled in the survey was 
relatively small. Our analyses are based on a convenience sample of YP attend- ing a GUM clinic 
and so are also at greater risk of having chlamydia  than  the  general  population  or than  those  
attending  other  services   for   testing.6   As with the survey of HCP, the YP’s survey is subject to 
response bias as young persons more aware of the NCSP may have been more inclined to 
participate in a survey about Chlamydia testing. We do not know the number of patients offered 
the survey in the study period due to variations in reception staff and their awareness of the study, 
despite regular reminders. 
 
Capturing information on the timing of events is particularly challenging, especially those not 
regarded as particularly salient or all that recent, for example, sexual debut. Thus, while we would 
have ideally had precise dates of testing and when people first and last had sex with their recent 
sexual partner(s), we instead asked respondents to estimate the time since testing and first sex 
with their partners such that we were only able to approximate the relative timing of testing. To 
minimise recall bias further and to reduce the pro- portion of the sample with missing data, we 
limited our analyses to the most recent of these events, but even then, data were only available for 
60% of our total sample. By only taking account of the most recent Chlamydia test, we may have 
overlooked earlier tests that occurred just before or soon after first sex with the most recent partner. 
Additionally, we could not fully capture an individual’s risk as we did not collect data on reasons for 
not yet having tested, which might include knowledge that their partner had been tested recently or 
continuous use of condoms. Despite these limitations, we identified some interesting features of 
the relative timing of Chlamydia testing, chiefly that there is substantial variation, suggesting that 
neither anticipating nor having sex with a new partner trigger testing for Chlamydia. These data 
therefore imply that the recommendation of ‘testing on change of sexual partner’ may rarely occur 
in practice. This represents potentially missed opportunities to interrupt transmission and the 
potential for infections to go untreated for several months, with the associated risks of developing 
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complications such as pelvic inflammatory disease in women or epididymitis in men. 
 
Our findings suggest there is room for improvement in relation to awareness of NCSP 
recommendations among both HCPs and sexually-active YP. Given this knowledge gap and a 
discord between testing recommendations and testing practice, further work is needed to develop 
targeted interventions with both HCPs and YP to support appropriate testing patterns in clinical 
practice. However, the relatively high proportions of respondents who were 
recommending/accessing testing also highlight that the relationship between knowledge and 
behaviour is not straightforward. The ‘COM-B’ model proposes that behaviour (B) is the result of 
an interaction between three components: capability (C), opportunity (O) and motivation (M).7 HCPs 
and YPs must have adequate knowledge (capability) the physical and social opportunity and the 
appropriate want or need (motivation) in order for Chlamydia testing to occur. Because low levels 
of knowledge among HCPs did not necessarily inhibit testing it may be that interventions to try and 
increase knowledge do not help to significantly improve testing rates. Interventions which address 
the motivation to test by increasing the perceived need or want to test following or before sex with 
a new partner may be useful for YP. In addition, targeting underlying beliefs (motivation) and peer 
norms (opportunities) around sex and relationships may also be helpful. Qualitative work with both 
HCPs and YP would be useful to develop a better understanding of how both groups interact with 
NCSP recommendations and how best to implement guidelines in a way that results in testing in 
line with recommendations. 
 
Further work to capture the complexity of testing in relation to sexual partnerships would be fruitful 
to better understand transmission risk and the potential duration of untreated infections. Better ways 
of capturing data on timing of testing in relation to partnership formation are needed, along with 
sufficient numbers of people who have been diagnosed, which would allow better understanding of 
how long people  have  untreated infections for. This would likely require some more in-depth 
qualitative work to develop the conceptual frameworks around testing practices, including focus 
group-based discussions.  This would in turn be useful to improve recommendations to YP and 
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Table 1: Awareness of NCSP guidance and reported frequency of recommending testing to 












Age limit (15-24 years)             
Aware of recommendation 13 (19%) 5 (13%) 8 (26%) 
Aware within 1 yearb  34 (49%) 19 (49%) 15 (48%) 
Not aware of recommendation 23 (33%) 15 (38%) 8 (26%) 
Annual testing              
Aware of recommendation 27 (26%) 20 (29%) 7 (20%) 
Always/sometimes recommends 23 (85%) 18 (90%) 5 (71%) 
Rarely/never recommends 4 (15%) 2 (10%) 2 (29%) 
Not aware of recommendation 77 (74%) 49 (71%) 28 (80%) 
Always/sometimes recommends 52 (70%) 34 (72%) 18 (67%) 
Rarely/never recommends 22 (30%) 13 (28%) 9 (33%) 
Testing on change of sexual partner             
Aware of recommendation 73 (70%) 48 (70%) 25 (100%) 
Always/sometimes recommends 70 (99%) 46 (98%) 24 (100%) 
Rarely/never recommends 1 (1%) 1 (2%) 0 (0%) 
Not aware of recommendation 31 (30%) 21 (30%) 0 (0%) 
Always/sometimes recommends 29 (97%) 20 (100%) 9 (90%) 
Rarely/never recommends 1 (3%) 0 (0%) 1 (10%) 
Re-test 3 months following a positive test             
Aware of recommendation 59 (58%) 42 (63%) 17 (50%) 
Always/sometimes recommends 55 (95%) 41 (98%) 14 (82%) 
Rarely/never recommends 3b (5%) 1 (2%) 3b (18%) 
Not aware of recommendation 42 (42%) 25 (37%) 17 (50%) 
Always/sometimes recommends 26 (67%) 16 (67%) 10 (67%) 
Rarely/never recommends 13 (33%) 8 (33%) 5 (33%) 
a Totals do not necessarily sum to total respondents in each group due to item non-response;  b Includes 2 who reported that 
they assumed another HCP would arrange this. b For example, 14-25 years, 15-26 years. 
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Table 2: Respondent characteristics, awareness of NCSP recommendations, reported testing 
and diagnosis histories (young people survey) 





  Female 
  Male 
  Transgender 
  Not stated 
 
Sexual orientation (n=195) 
  Heterosexual 
  Homosexual/bisexual 
  Not reported 
 
Ethnicity (n=195) 
  White 
  Mixed 
  Black African 
  Asian 
  Black Caribbean 
  Other/not stated 
 
Awareness of NCSP testing recommendations: 
  Annual testing (n=167) 
  Testing on change of sexual partner (n=169) 
 
Sexual Experience: 
  Ever had sex (n=193) 
  Age at sexual debut (median, range) (n=172) 
  Number of partners in last year (median, range) (n=174) 


































































Self-reported chlamydia testing behaviour: 
  Ever tested (n=190) 






  Tests in the last year (n=190) 
  Tests annually (n=163) 
  Re-tests 3 months following a positive test (n=36)a 
 
Chlamydia diagnosis history (n=188): 
  Never 
  Once 
  2+ 
 
Happy to be offered a chlamydia test each time saw a doctor/nurse 
(n=161): 
  Yes 
  No 













































Note for Table 2: denominators for each question vary so are given in brackets. aOnly those with a positive chlamydia test in the 
past were asked to comment on this, 17 did not comment. 
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